So-Young International Inc: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über So-Young International Inc Unternehmen

So-Young International Inc is a holding company mainly engaged in online platform for discovering, evaluating and reserving medical aesthetic services. The Company operates its businesses through two segments including So-Young segment and Wuhan Miracle segment. So-Young segment mainly provides information services, reservation services, aesthetic treatment services and sales of medical products and maintenance services. Wuhan Miracle segment is mainly engaged in the research and development, production, sales and agency of laser and other optoelectronic medical equipment. The Company operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website.

So-Young International Inc Informationen



BörsenkürzelSY

Name des UnternehmensSo-Young International Inc

IPO-datumMay 02, 2019

CEOJin (Xing)

Anzahl der mitarbeiter1800

WertpapierartDepository Receipt

GeschäftsjahresendeMay 02

Addresse2/F, East Tower, Poly Plaza, No. 66 Xiangbin Road, Chaoyang District

StadtBEIJING

BörseNASDAQ OMX - NASDAQ BASIC

LandChina

Postleitzahl100102

Telefon861087902012

Websitehttps://www.soyoung.com/

BörsenkürzelSY

IPO-datumMay 02, 2019

CEOJin (Xing)

Führungskräfte von So-Young International Inc



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Xing Jin

Chairman of the Board, Chief Executive Officer, Co-Founder

--

Dr. Haipeng Zhang, M.D.

Independent Director

--

Prof. Chao He

Independent Director

--

Mr. Xiaodong Ying

Chief Technology Officer, Director

--

Mr. Nan Huang

Chief Human Resources Officer

--

Mr. Hui Zhao

Chief Financial Officer, Director

--

Ms. Nan Shen

Independent Director

--

Ms. Mona Qiao

Investor Relations

--

Ms. Bei Wang

Chief Marketing Officer

--

Ms. Gefei Li

Chief Operating Officer

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Xing Jin

Chairman of the Board, Chief Executive Officer, Co-Founder

--

Dr. Haipeng Zhang, M.D.

Independent Director

--

Prof. Chao He

Independent Director

--

Mr. Xiaodong Ying

Chief Technology Officer, Director

--

Mr. Nan Huang

Chief Human Resources Officer

--

Mr. Hui Zhao

Chief Financial Officer, Director

--

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Information services and other

998.81M

79.40%

Sales of equipment and maintenance services

259.07M

20.60%

Nach RegionUSD

Name

Umsatz

Anteil

China (Mainland)

1.47B

0.00%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Information services and other

998.81M

79.40%

Sales of equipment and maintenance services

259.07M

20.60%

Aktionärsstatistik

Aktualisiert: Sun, Feb 1

Aktionäre

Aktionärstypen

Aktionäre

Anteil

Matrix Partners China

9.62%

TB Alternative Assets Ltd.

3.65%

Morgan Stanley & Co. LLC

1.30%

Kadensa Capital Limited

1.22%

Areo Holdings Ltd

0.84%

Andere

83.36%

Aktionäre

Anteil

Matrix Partners China

9.62%

TB Alternative Assets Ltd.

3.65%

Morgan Stanley & Co. LLC

1.30%

Kadensa Capital Limited

1.22%

Areo Holdings Ltd

0.84%

Andere

83.36%

Aktionärstypen

Aktionäre

Anteil

Venture Capital

9.62%

Investment Advisor

5.26%

Hedge Fund

3.24%

Research Firm

2.87%

Corporation

1.12%

Investment Advisor/Hedge Fund

0.41%

Pension Fund

0.02%

Andere

77.45%

Institutionelle Beteiligung



Aktualisiert: Thu, Jan 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q4

60

18.01M

21.43%

-2.31M

2025Q3

50

16.48M

19.69%

+799.52K

2025Q2

56

5.46M

6.45%

+3.53M

2025Q1

56

39.98M

47.25%

+2.34M

2024Q4

57

35.00M

40.69%

-4.68M

2024Q3

62

35.08M

40.78%

-22.79M

2024Q2

68

35.66M

41.41%

-22.81M

2024Q1

74

35.91M

41.67%

-24.80M

2023Q4

80

36.94M

43.37%

-24.33M

2023Q3

100

42.94M

49.19%

-27.05M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

Matrix Partners China

8.09M

9.62%

-4.18M

-34.07%

Sep 30, 2025

TB Alternative Assets Ltd.

3.07M

3.65%

--

Sep 30, 2025

Morgan Stanley & Co. LLC

1.09M

1.3%

+1.08M

+7747.86%

Sep 30, 2025

Kadensa Capital Limited

1.02M

1.22%

+1.02M

--

Sep 30, 2025

Areo Holdings Ltd

709.77K

0.84%

--

Feb 28, 2025

Citi Investment Research (US)

675.12K

0.8%

+626.96K

+1301.89%

Sep 30, 2025

Renaissance Technologies LLC

562.53K

0.67%

-700.00

-0.12%

Sep 30, 2025

Barclays Bank PLC

497.63K

0.59%

-126.17K

-20.23%

Sep 30, 2025

HCEP Management Limited

490.70K

0.58%

+490.70K

--

Sep 30, 2025

Nomura Securities Co., Ltd.

326.87K

0.39%

+326.87K

--

Sep 30, 2025

Verbundene ETFs



Aktualisiert: Sat, Dec 6

Name

Anteil

Invesco Golden Dragon China ETF

0.11%

SPDR S&P Emerging Markets Small Cap ETF

0.02%

Avantis Emerging Markets Small Cap Equity ETF

0.01%

SPDR S&P China ETF

0.01%

ActivePassive International Equity ETF

0%

Invesco Golden Dragon China ETF

Anteil0.11%

SPDR S&P Emerging Markets Small Cap ETF

Anteil0.02%

Avantis Emerging Markets Small Cap Equity ETF

Anteil0.01%

SPDR S&P China ETF

Anteil0.01%

ActivePassive International Equity ETF

Anteil0%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten

Datum

Ex-Dividendentag

Art

Verhältnis

Keine Daten